SLS Stock Chart

SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. Its lead product candidate, galinpepimut-S (GPS), is a cancer immunotherapeutic agent that targets a spectrum of hematologic cancers and solid tumor indications. The company was formed as a result of a merger between Galena Biopharma and SELLAS Life Sciences Group Ltd.